All
New Hope for Treating the 4 Main Types of Epidermolysis Bullosa
Recent advancements in the understanding of epidermolysis bullosa have resulted in a fine-tuning of the classification of the disease group as well as the development of new possible therapies.
Survey Finds Women With HS Possess Higher Infertility Rates
An anonymous, online survey was conducted through HS support groups from June 2022 to July 2022.
Delivery Method Of Hyaluronic Acid In Infraorbital Region Affects Adverse Events Outcome
Study authors found that injection with a needle resulted in a higher incidence of ecchymosis.
Risankizumab Met Co-Primary Endpoints in Patients With Moderate Plaque Psoriasis
AbbVie announced that patients treated with risankizumab achieved significantly higher results than those given apremilast.
Genetic Variations May Play Role in Acne Vulgaris, According to Lipid Profile Variation Estimates
Researchers found that lipid profile levels were higher in patients with acne vulgaris compared to otherwise healthy patients.
Journal Digest: July 26
This week’s collection of the latest dermatologic studies covers benzoyl peroxide gel with oral doxycycline compared to lymecycline, interactions between the aesthetic device industry and dermatologists, nasal soft tissue pliability, and Merkel cell carcinoma in situ with reticulated infundibulocystic proliferation.
1 in 3 Dermatologists Do Not Counsel Patients With HS on Wound Care
Furthermore, a survey showed that more than half of providers do not discuss clothing modifications, and half report providing patients with wound care supplies that are covered by insurance.
Improving the Quality of Life for Patients With Albinism
Quality of life is impacted far beyond the physical challenges for those with oculocutaneous albinism.
Staphylococcus Aureus Mutations During Treatment For Atopic Dermatitis
Researchers found that treatment for atopic dermatitis could contribute to a higher mutation rate.
Canadian Skin of Colour & Diversity Scholarship Program Will Improve Care for Underrepresented Populations
Programs will address an education or care gap in skin of color that is not being met in dermatological care.
Skin Microbiome Diversity Lower With Soap and Water Compared With Hand Sanitizer Use
Using hand washing and alcohol-based hand sanitizer use during the COVID-19 pandemic as a baseline, researchers evaluated the effects of these behaviors on the skin’s microbiome.
Masters of Pediatric Dermatology Course Offered to Healthcare Providers
LiVDerm and the Masters of Pediatric Dermatology Symposium have developed a 6-module course that covers some of the most common skin care conditions in pediatric patients.
POLL: Do You Encounter Patients Who Are Unaware of the Risks of Skin Lightening Products?
Click here to answer this week's poll.
Systemic Oxidative Stress Plays Role in Etiopathogenesis of Melasma
Researchers noted that serum levels of malondialdehyde and vitamin C are indicators of the impairment caused by systemic oxidative stress.
Facial Cosmetics: The Creation of Illusion
In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, reviews recent advances in cosmetics and the illusions they create.
Guselkumab, Ustekinumab Led to 2 Years of Sustained Improvements in Patients With Psoriasis
In the PERSIST study, improvements were sustained through week 104.
Ritlecitinib and Nivolumab Receive Positive CHMP Opinions
Both therapies for alopecia areata and completely resected stage IIB/C melanoma could be approved by the EC for patients aged 12 years or older.
First Patient Receives Upadacitinib in Phase 3 Trial For Treatment of Hidradenitis Suppurativa
AbbVie announced that treatment has begun in the first randomized, placebo-controlled, double-blind, multicenter study.
Children of Mothers With Alopecia Areata More Likely to Develop Certain Disorders
A study found that maternal alopecia areata led to a significantly higher incidence of childhood development of autoimmune, psychiatric, thyroid, and other disorders.
AAD, Janssen, and Kenvue Partner to Mentor Next Generation of Dermatologists
Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.
Psychological Effects of Cosmetic Procedures Extend Far Beneath the Surface
Understanding the underlying motivation for seeking out minimally invasive cosmetic procedures is important to provide individualized and holistic care to patients.
Derm In The News: July 16-22
Keep up with the latest headlines in dermatology from the past week, including Novan, Inc.'s bankruptcy filing, rates of melanoma in European Union countries, and more.
The Weekly Roundup: July 17-21
ICYMI, this week we had stories about managing Merkel cell carcinoma in patients with skin of color, addressing disparities in atopic dermatitis with telehealth, ruxolitinib for rapid pruritus reduction, and more.
VP-102 Now Approved for the Treatment of Molluscum Contagiosum
Verrica’s VP-102 is the first FDA-approved treatment for molluscum lesions.
The Adalimumab Biosimiliar Pipeline: What's Ahead
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Autologous Cell Therapy Effective in Wound Treatment
Researchers applied EB-101, a new cell therapy, to patients with recessive dystrophic epidermolysis bullosa with positive results.
Grant Program Accepting Applications, Seeks to Bridge Care Gap in Inflammatory Dermatoses
Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.
Study Observes Correlations Between COVID-19 and Psoriasis
A recent study found no correlation between a genetic predisposition to psoriasis or systemic treatment for psoriasis and an increase in the severity of COVID-19 illness.
Real-World Cohort Study to Compare Efficacy and Safety of Adalimumab Biosimilars for Psoriasis
Study results are expected to be presented at international dermatology conferences by the end of the year.
Sexually-Diverse Patient Populations Face Higher Prevalence of Atopic Disease
Compared to patients who identified as heterosexual, patients in the LGBTQ+ community have a higher prevalence of atopic dermatitis, asthma, and allergic rhinitis.